Who are SpringWorks Therapeutics's investors?

SpringWorks Therapeutics's investors include Bain Capital Life Sciences, Pfizer Venture Investments, Bain Capital, Biotechnology Value Fund, HBM Healthcare Investments, LifeArc Ventures, OrbiMed, Samsara BioCapital.

How much funding has SpringWorks Therapeutics raised?

SpringWorks Therapeutics has disclosed $125M raised across 1 round.

Where is SpringWorks Therapeutics headquartered?

SpringWorks Therapeutics is headquartered in Stamford, US.

SpringWorks Therapeutics

Stamford, US · Founded 2019 · Delaware corporation · 16 known investors

Find your way into SpringWorks Therapeutics

414 people in our graph share verified history with the SpringWorks Therapeutics team — schools, employers, funds. One of them is your warm intro.

Nessan Berminghamunlockedknows Dan Lynch · together at Xilio Therapeutics (overlapped)

×2knows the team · via Xilio Therapeutics

×5knows the team · via Blueprint Medicines

×4knows the team · via Wesleyan University

Healthtech

Founders & leadership

Daniel S. Lynch ExecutiveInvestor at GV (Google Ventures)

Saqib IslamExecutive

Michael GrecoExecutive

Board

Stephen SquintoBoard directorVenture Partner at OrbiMed

Deval PatrickBoard director

Carl L Gordon Board directorManaging Partner at OrbiMed

Freda Lewis-HallBoard director

Jeffrey SchwartzBoard directorExecutive Officer at Bain Capital Life Sciences

Peter KeenNon Executive Director2017–2019Angel

Investors · 16

Bain Capital Life Scienceslisted by Bain Capital Life SciencesBoston

How we know: Bain Capital Life Sciences's portfolio page · funding news · globalgenes.org · Not right? Tell us

Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M

How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us

Bain Capitalreported

How we know: pharmaceutical-technology.com · Not right? Tell us

Biotechnology Value FundreportedSan Francisco

How we know: pharmaceutical-technology.com · Not right? Tell us

HBM Healthcare InvestmentsreportedZug

How we know: pharmaceutical-technology.com · Not right? Tell us

LifeArc VenturesreportedLondon

How we know: globalgenes.org · Not right? Tell us

OrbiMedreportedNew York · $1M – $75Mvia Stephen Squinto · board

How we know: board seat on SEC Form D · funding news · globalgenes.org · Not right? Tell us

Samsara BioCapitalreportedMenlo Park

How we know: pharmaceutical-technology.com · Not right? Tell us

Also in the syndicate · 8

ArrowMark PartnersBoxer CapitalGlaxoSmithKlineLaurion Capital ManagementLifeArcPerceptive AdvisorsleadPfizerSurveyor Capital

Funding

SEC filings, press & company announcements

$125M disclosed across 1 round · 2019

$103MSeries ASep 2017 · 2 sources
Bain Capital Double Impact, Bain Capital Life Sciences, LifeArc, OrbiMed, Pfizer
Source ↗

▶$125MraisedApr 2019 · 26 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Freda Lewis-HallDirector
Stephen SquintoDirector
Jeffrey SchwartzDirector
Deval PatrickDirector
Daniel S. LynchExecutive Officer, Director
Saqib IslamExecutive Officer, Director
Michael GrecoExecutive Officer
Carl L GordonDirector
Peter KeenDirector

Offering amount: $125M
Amount sold: $125M
First sale: Mar 2019
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are SpringWorks Therapeutics's investors?: SpringWorks Therapeutics's investors include Bain Capital Life Sciences, Pfizer Venture Investments, Bain Capital, Biotechnology Value Fund, HBM Healthcare Investments, LifeArc Ventures, OrbiMed, Samsara BioCapital.
How much funding has SpringWorks Therapeutics raised?: SpringWorks Therapeutics has disclosed $125M raised across 1 round.
Where is SpringWorks Therapeutics headquartered?: SpringWorks Therapeutics is headquartered in Stamford, US.